Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 125 | 125 | 125 |
| Gross Profit | N/A | N/A | 125 | 125 | 125 |
| Operating Expenses | 33,371 | 38,391 | 34,847 | 25,851 | 13,935 |
| Operating Income | -33,371 | -38,391 | -34,722 | -25,726 | -13,810 |
| Interest Expense | 2,090 | 2,595 | 1,708 | 0 | 0 |
| Other Income | -19,716 | 3,047 | 17,636 | -10,398 | -3,870 |
| Pre-tax Income | -55,177 | -37,939 | -18,794 | -36,124 | -17,680 |
| Net Income Continuous | -55,177 | -37,939 | -18,794 | -36,124 | -17,680 |
| Net Income | $-55,177 | $-37,939 | $-18,794 | $-36,124 | $-17,680 |
| EPS Basic Total Ops | -1.74 | -1.31 | -0.65 | -1.91 | -1.52 |
| EPS Basic Continuous Ops | -1.74 | -1.31 | -0.65 | -1.91 | -1.52 |
| EPS Diluted Total Ops | -1.74 | -1.31 | -0.65 | -1.91 | -1.52 |
| EPS Diluted Continuous Ops | -1.74 | -1.31 | -0.65 | -1.91 | -1.52 |
| EPS Diluted Before Non-Recurring Items | -1.74 | -1.31 | -0.65 | -0.41 | N/A |
| EBITDA(a) | $-32,381 | $-37,431 | $-33,944 | $-25,494 | $-13,719 |